Characterizing the Immune Response and Neuronal Damage in COVID-19
Clinical trial NCT04510012 · COMPLETED
Trial details
- NCT number
- NCT04510012
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-03-05
- Primary completion
- 2020-12-18
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.